LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
0.930
+0.041 (4.53%)
Feb 11, 2025, 1:46 PM EST - Market open
LAVA Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 11, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jan '20 Jan 1, 2020 |
| Market Capitalization | 24 | 42 | 92 | 142 | - | - |
| Market Cap Growth | 12.96% | -54.86% | -35.10% | - | - | - |
| Enterprise Value | -49 | -57 | 4 | 4 | - | - |
| Last Close Price | 0.91 | 1.58 | 3.50 | 5.50 | - | - |
| PS Ratio | 3.37 | 6.14 | 4.75 | 26.50 | - | - |
| PB Ratio | 0.73 | 0.81 | 1.07 | 1.20 | - | - |
| P/TBV Ratio | 1.32 | 0.81 | 1.07 | 1.20 | - | - |
| P/FCF Ratio | - | - | 26.62 | - | - | - |
| P/OCF Ratio | - | - | 22.76 | - | - | - |
| EV/Sales Ratio | - | - | 0.20 | 0.81 | - | - |
| EV/FCF Ratio | - | - | 1.13 | - | - | - |
| Debt / Equity Ratio | 0.19 | 0.12 | 0.06 | 0.04 | 0.54 | 0.30 |
| Debt / FCF Ratio | - | - | 1.58 | - | - | - |
| Asset Turnover | 0.08 | 0.06 | 0.14 | 0.07 | 0.26 | - |
| Quick Ratio | 5.26 | 6.51 | 6.20 | 11.91 | 2.36 | 5.31 |
| Current Ratio | 5.36 | 6.62 | 6.40 | 12.14 | 2.48 | 5.35 |
| Return on Equity (ROE) | -63.12% | -61.18% | -31.22% | -67.24% | -236.57% | - |
| Return on Assets (ROA) | -18.03% | -22.06% | -15.41% | -34.13% | -62.63% | - |
| Return on Capital (ROIC) | -35.02% | -36.29% | -20.28% | -40.40% | -94.97% | - |
| Earnings Yield | -115.28% | -101.05% | -34.68% | -29.88% | - | - |
| FCF Yield | -119.38% | -95.58% | 3.76% | -20.75% | - | - |
| Buyback Yield / Dilution | -3.18% | -3.12% | -31.21% | -4850.36% | 10.81% | - |
| Total Shareholder Return | -3.18% | -3.12% | -31.21% | -4850.36% | 10.81% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.